Medication Administration Note (PRN, Refusal, or Adverse Reaction)

Event Type: [PRN Administered / Refused / Held / Late or Missed / Suspected Adverse Reaction]

Event Date/Time: [date and time of medication event]

Medication: [generic name, dose, route, frequency or PRN interval, ordered indication/parameters]

Late Entry: Yes — [source of information: direct observation / patient report / caregiver report / chart review / device data] (Include only if documentation time differs significantly from event time; otherwise omit this line.)

(Use specific, measurable data and maintain chronological order. Cross-reference the MAR for structured administration details. Use "suspected" language for adverse reactions unless causality is confirmed.)

Indication and Pre-Assessment

• Clinical trigger/rationale: [patient-reported symptom or clinical reason prompting action]
• Baseline severity/metric: [validated scale name and score, or objective descriptor] (Use validated scale when available for PRN administration.)
• Pertinent vitals/assessments: [relevant vital signs and focused assessment findings]
• Non-pharmacologic measures attempted: [measures and response] (Include if performed prior to PRN administration.)
• Refusal/Hold rationale: [patient-stated reason or clinical parameters supporting hold] (Include for Refused or Held events.)
• Suspected adverse reaction context: [baseline status, timing relative to suspected agent, relevant risk factors] (Include for suspected reactions.)
• Assessment limitations: [why assessment was limited and surrogate data used] (Include only if standard assessment was not possible.)

Action Taken

• Administration status: [administered as ordered / not administered — clinically relevant context not captured in MAR]
• Refusal counseling: [risks discussed, alternatives offered, patient response] (Include for Refused events.)
• Hold rationale and recheck plan: [clinical parameters and timing for re-evaluation] (Include for Held events.)
• Delay/missed dose reason: [specific reason and risk mitigation steps taken] (Include for Late or Missed events.)
• Suspected ADR immediate actions: [medication stopped/held, supportive care provided, rescue medications and response] (Include for suspected adverse reactions.)
• Patient education: [key points communicated, patient understanding, safety instructions] (Include for refusals and high-risk PRNs.)

Reassessment and Outcome

• Reassessment time: [date and time]
• Effectiveness: [same metric as baseline with current score/descriptor]
• Adverse effects observed: [signs/symptoms and severity, or none noted]
• Objective monitoring: [relevant vitals and exam findings post-intervention]
• Next steps if not effective: [additional measures taken or planned] (Include if initial response was inadequate.)
• Reassessment limitations: [reason reassessment could not be completed and planned follow-up] (Include only if applicable.)
• Current status and plan: [concise summary of patient status and immediate plan]

Escalation and Notifications

(Include this section only when notifications occurred or when absence of notification may be questioned.)

• Notifications: [provider / pharmacy / charge nurse / other] — [name or role, date/time notified]
• Information communicated: [summary of clinical information shared and any orders received]
• Allergy/adverse reaction list updated: [Yes / No / N/A] (Include for suspected adverse reactions.)
• Facility reporting: [Yes / No] — [report or incident ID] (Include for suspected adverse reactions per facility policy.)
• Rationale for no notification: [brief justification] (Include only if notification might be expected but was not made.)